Literature DB >> 17993618

DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia.

Annegret Glasow1, Angela Barrett, Kevin Petrie, Rajeev Gupta, Manuel Boix-Chornet, Da-Cheng Zhou, David Grimwade, Robert Gallagher, Marieke von Lindern, Samuel Waxman, Tariq Enver, Guido Hildebrandt, Arthur Zelent.   

Abstract

The retinoic acid receptor (RAR) alpha gene (RARA) encodes 2 major isoforms and mediates positive effects of all-trans retinoic acid (ATRA) on myelomonocytic differentiation. Expression of the ATRA-inducible (RARalpha2) isoform increases with myelomonocytic differentiation and appears to be down-regulated in many acute myeloid leukemia (AML) cell lines. Here, we demonstrate that relative to normal myeloid stem/progenitor cells, RARalpha2 expression is dramatically reduced in primary AML blasts. Expression of the RARalpha1 isoform is also significantly reduced in primary AML cells, but not in AML cell lines. Although the promoters directing expression of RARalpha1 and RARalpha2 are respectively unmethylated and methylated in AML cell lines, these regulatory regions are unmethylated in all the AML patient cell samples analyzed. Moreover, in primary AML cells, histones associated with the RARalpha2 promoter possessed diminished levels of H3 acetylation and lysine 4 methylation. These results underscore the complexities of the mechanisms responsible for deregulation of gene expression in AML and support the notion that diminished RARA expression contributes to leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17993618     DOI: 10.1182/blood-2007-05-088344

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

1.  Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia.

Authors:  Tino Schenk; Weihsu Claire Chen; Stefanie Göllner; Louise Howell; Liqing Jin; Katja Hebestreit; Hans-Ulrich Klein; Andreea C Popescu; Alan Burnett; Ken Mills; Robert A Casero; Laurence Marton; Patrick Woster; Mark D Minden; Martin Dugas; Jean C Y Wang; John E Dick; Carsten Müller-Tidow; Kevin Petrie; Arthur Zelent
Journal:  Nat Med       Date:  2012-03-11       Impact factor: 53.440

2.  Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database.

Authors:  Gloria Manzotti; Sandra Parenti; Giovanna Ferrari-Amorotti; Angela Rachele Soliera; Sara Cattelani; Monica Montanari; Daniel Cavalli; Adam Ertel; Alexis Grande; Bruno Calabretta
Journal:  Cell Cycle       Date:  2015-06-23       Impact factor: 4.534

3.  Rara haploinsufficiency modestly influences the phenotype of acute promyelocytic leukemia in mice.

Authors:  John S Welch; Jeffery M Klco; Nobish Varghese; Rakesh Nagarajan; Timothy J Ley
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

4.  What potential is there for LSD1 inhibitors to reach approval for AML?

Authors:  Manu R Pandey; Eunice S Wang
Journal:  Expert Opin Emerg Drugs       Date:  2019-12       Impact factor: 4.191

Review 5.  The roles of retinoic acid and retinoic acid receptors in inducing epigenetic changes.

Authors:  Alison Urvalek; Kristian Bruun Laursen; Lorraine J Gudas
Journal:  Subcell Biochem       Date:  2014

6.  Clinical Responsiveness to All-trans Retinoic Acid Is Potentiated by LSD1 Inhibition and Associated with a Quiescent Transcriptome in Myeloid Malignancies.

Authors:  Mina M Tayari; Helena G Dos Santos; Ronan T Swords; Justin M Watts; Deukwoo Kwon; Terrence J Bradley; Amber Thomassen; Charles Chen; Yvonne Dinh; Aymee Perez; Arthur Zelent; Lluis Morey; Luisa Cimmino; Ramin Shiekhattar
Journal:  Clin Cancer Res       Date:  2021-01-25       Impact factor: 13.801

7.  Sensitivity of MLL-rearranged AML cells to all-trans retinoic acid is associated with the level of H3K4me2 in the RARα promoter region.

Authors:  K Sakamoto; T Imamura; M Yano; H Yoshida; A Fujiki; Y Hirashima; H Hosoi
Journal:  Blood Cancer J       Date:  2014-04-25       Impact factor: 11.037

8.  Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia.

Authors:  Sonja Röhrs; Wilhelm G Dirks; Claus Meyer; Rolf Marschalek; Michaela Scherr; Robert Slany; Andrew Wallace; Hans G Drexler; Hilmar Quentmeier
Journal:  Mol Cancer       Date:  2009-10-16       Impact factor: 27.401

Review 9.  Cigarette smoke-induced alterations in blood: A review of research on DNA methylation and gene expression.

Authors:  Constanza P Silva; Helen M Kamens
Journal:  Exp Clin Psychopharmacol       Date:  2020-07-13       Impact factor: 3.157

10.  Retinoid differentiation therapy for common types of acute myeloid leukemia.

Authors:  Geoffrey Brown; Philip Hughes
Journal:  Leuk Res Treatment       Date:  2012-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.